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Abstract
Normothermic machine perfusion has previously been demonstrated to restore damaged warm ischemic livers to
transplantable condition in animal models. However, the mechanisms of recovery are unclear, preventing rational
optimization of perfusion systems and slowing clinical translation of machine perfusion. In this study, organ recovery time
and major perfusate shortcomings were evaluated using a comprehensive metabolic analysis of organ function in perfusion
prior to successful transplantation. Two groups, Fresh livers and livers subjected to 1 hr of warm ischemia (WI) received
perfusion for a total preservation time of 6 hrs, followed by successful transplantation. 24 metabolic fluxes were directly
measured and 38 stoichiometrically-related fluxes were estimated via a mass balance model of the major pathways of
energy metabolism. This analysis revealed stable metabolism in Fresh livers throughout perfusion while identifying two
distinct metabolic states in WI livers, separated at t = 2 hrs, coinciding with recovery of oxygen uptake rates to Fresh liver
values. This finding strongly suggests successful organ resuscitation within 2 hrs of perfusion. Overall perfused livers
regulated metabolism of perfusate substrates according to their metabolic needs, despite supraphysiological levels of some
metabolites. This study establishes the first integrative metabolic basis for the dynamics of recovery during perfusion
treatment of marginal livers. Our initial findings support enhanced oxygen delivery for both timely recovery and long-term
sustenance. These results are expected to lead the optimization of the treatment protocols and perfusion media from a
metabolic perspective, facilitating translation to clinical use.
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Introduction
Transplantation is currently the only treatment option for end-
stage liver disease but it is limited by the lack of high quality donor
organs. An area of keen investigation is into the use of machine
perfusion (MP) as a means of resuscitating presently non-
transplantable donor organs after cardiac death (DCD), thereby
significantly increasing the donor organ pool [1,2]. Porcine and
murine models of DCD livers are significantly improved by MP
compared to organs preserved by the gold standard of static cold
storage [3], and furthermore, normothermic machine perfusion
(NMP) is necessary for their successful transplantation [4,5,6,7].
While MP is particularly well-suited to dynamic evaluation of
organ function, methods for standardized quantitative analysis are
only emerging very recently [8]. Optimization of perfusion
parameters such as temperature, flow rate, perfusion media and
the ideal oxygen carrier [9] continue to dominate most research
efforts. Two fundamental questions remain unanswered: What
should the liver be perfused with and how long should it be
perfused for?
Optimizing the perfusate addresses the optimization of the
metabolic state of the liver during MP. During perfusion, ATP
levels recover [10,11] alleviating some aspects of ischemia-
reperfusion injury, and this is well-correlated with enhanced
transplant success. However, existing studies typically focus on a
few global indicators of energy recovery, which by themselves are
nonspecific, and so do not enable definitive conclusions to be
reached regarding the limitations of the perfusion system and
protocol employed. Lactate accumulation, for example, occurs
during anaerobic metabolism from hypo-perfusion [12], normal
erythrocyte metabolism [13] and in the absence of an initial lactate
concentration in the perfusion medium [14]. Other frequently
used parameters, such as trends in glucose metabolism, degree of
oxygen consumption, ability to produce albumin or other complex
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proteins, rates of excess amino acid breakdown and urea
formation [3,15,16] similarly reflect multiple likely pathways of
activity that will provide more specific information if evaluated in a
cohesive manner.
Endeavoring towards a standardized approach to organ
recovery and rational perfusion optimization, we employed a
comprehensive Metabolic Flux Analysis [17] model of whole-
organ metabolism [18] to dynamically assess the function of the
liver during perfusion. The mathematical model stoichiometrically
correlates 28 measured and 34 calculated metabolite rates of
uptake or release (i.e. fluxes) from hourly perfusion time points of
organs that were subsequently successfully transplanted (.1
month survival). Using the temporal profiles of the measured
fluxes, a significant metabolic turnaround signaling recovery of
warm ischemic livers, was observed within 2 hours of perfusion;
oxygen uptake rate (OUR) most dramatically illustrated this event.
Metabolic Flux Analysis (MFA) comparison of perfused ischemic
livers to perfused Fresh livers highlighted the impact of NMP on
organ function and identified system-specific shortcomings. This
approach enables future perfusion optimizations for long-term
organ storage and recovery.
Materials and Methods
Animals
Male Lewis rats weighing 200–300 g were obtained from
Charles River Laboratories (Wilmington, MA) and maintained in
accordance with National Research Council guidelines. The
Subcommittee on Research Animal Care, Committee on
Research at the Massachusetts General Hospital, approved the
experimental protocols. All animals were allowed to acclimatize
for at least 2 days prior to any experimentation. Procured livers
were either Fresh (n = 11) or exposed to an hour of warm ischemia
(WI, n = 7).
Isolation of Donor Livers
Full details of the procedure are described elsewhere [5]. Briefly,
a transverse abdominal incision was made and the intestines
retracted to expose the portal vein (PV), the common bile duct
(CBD), and the inferior vena cava (IVC). The CBD was
cannulated (22 G polyethylene stent, Surflo, Terumo, Somerset,
NJ) and the IVC freed from the right renal and adrenal veins. The
portal vein (PV) was freed from the splenic and gastroduodenal
veins. The right phrenic vein emptying into the supra-hepatic vena
cava (SHVC) was ligated. Heparin (200 U) was injected into the
penile vein. The IVC and PV were clamped. For Fresh livers, an
18G polyethylene cannula (Terumo) was inserted into the PV, and
the liver was flushed with 5 mL of cold (4uC) University of
Wisconsin (UW) solution (Viaspan, Barr Laboratories, Pamona,
NY). The diaphragm was opened, the SHVC was transected, and
the liver was flushed with an additional 5 mL of UW solution. The
liver was removed, weighed, and placed in a bowl of ice-cold UW
solution to be cuffed. For WI livers, flushing of the organ via the
PV was omitted. After isolation from the donor, these livers were
then weighed and placed in a temperature-controlled chamber
filled with saline and maintained at 3460.1uC for 1 hr. During
this period the portal vein (PV) and inferior vena cava (IVC) were
cuffed.
Normothermic Liver Perfusion and Metabolite Sampling
The perfusion medium comprised phenol red-free Williams
Medium E (WE, Sigma Chemical, St. Louis, MO) chosen for its
similarity to in vivo influxes (Appendix S1 and Table 1). WE was
supplemented with 2 u/L insulin (28.85units/mg Humulin, Eli
Lily, Indianapolis, IN), 100,000 u/L penicillin, 100 mg/L strep-
tomycin sulfate (Gibco, Invitrogen, Grand Island, NY), 0.292 g/L
L-glutamine (Gibco), 10 mg/L hydrocortisone (Solu-Cortef,
Pharmacia & Upjohn, Kalamazoo, MI), and 1000 u/L heparin
(APP, Schaumberg, IL). The primary circuit of the perfusion
system comprised perfusion medium (‘‘perfusate’’) that recirculat-
ed by means of a peristaltic pump through a jacketed perfusion
chamber, a membrane oxygenator, a heat exchanger, and a
bubble trap. The oxygenator was gassed with a mixture of
74%N2/21%O2/5%CO2 and 100%O2 to maintain a constant
pH. Fresh rat plasma (25% v/v) and erythrocytes (18–20% v/v)
were collected earlier [5] and added to the perfusate. The total
perfusate volume was 55–60 mL. Perfusate hematocrit was
sustained, nutrients were replenished, and metabolism by-products
were diluted through dialysis. A hollow fiber dialyzer with a
2200 cm2 membrane area and a 30 kDa nominal molecular cutoff
weight (SpectrumLabs, Rancho Dominguez, CA) enabled coun-
ter-current mixing of perfusate in the primary circuit with a
reservoir of WE (‘‘dialysate’’) in a secondary circuit. Temperature
within the system was maintained at 37.5uC. Upon completion of
cuffing of Fresh livers (,5 min) and after the period of warm
ischemia for WI livers, they were immersed in perfusate in the
perfusion chamber. Livers were perfused at a constant flow rate
through the portal vein [5] while maintaining portal pressure
between 10–12 cmH2O. The effluent flowed freely from the
SHVC and IVC into the surrounding medium. Perfusate and
dialysate samples (1 mL) were collected hourly from the liver
effluent and reservoir respectively. Perfusate samples were first
spun down at 3000 g before storing the supernatant at 280uC.
Oxygen delivery and exit rates were determined from samples
taken immediately prior to entry to the portal vein and from the
IVC. When the recipient hepatectomy was prepared, the liver was
disconnected from the circuit, rinsed in a bowl of saline at room
temperature, and weighed again before transplantation.
Biochemical Assays. Blood gases were determined immedi-
ately using a blood gas analyzer (Rapidlab, Chiron Diagnostics,
Norwood, MA). Oxygen concentration delivered and removed
from the liver was calculated using the following equation:
[O2] = (1.396[Hb]6FO2Hb)+0.003146pO2, which expresses the
concentration of oxygen (ml/dL of blood) as the sum of oxygen
bound to hemoglobin and free in plasma. [Hb] (g/dL) is the
concentration of hemoglobin, FO2Hb is the fraction of oxyhemo-
globin present, 1.39 (mlO2/g Hb) is the binding capacity of oxygen
to hemoglobin and 0.00314 (mlO2/dL/mmHg) is the solubility
coefficient of oxygen in plasma, which is dependent on the partial
oxygen tension in the blood, pO2 (mmHg). The rate of oxygen
delivery to the liver (ODR) and exit from the liver (OER) is
subsequently a product of the oxygen concentration [O2] at the
site of entry and departure to the liver, respectively, and the flow
rate V (ml/min), normalized to the weight W (g) of the liver. The
difference between the two rates provides the hepatic oxygen
uptake rate: OUR=ODR-OER.
Similarly, total carbon dioxide release rate (CRR) at each time
point was calculated as the difference between total carbon dioxide
(tCO2outlet) released at the outlet of the liver and the total carbon
dioxide entering the liver (tCO2inlet), multiplied by the flow rate V
(ml/min) and normalized to the weight of the liver, W (g). Total
carbon dioxide of perfusate samples taken at the inlet and outlet of
the liver was measured via Piccolo Blood Chemistry Analyzer
(Abaxis).
Urea was assayed by reaction with diacetyl monoxime using a
commercial assay kit (BUN, Sigma-Aldrich, St. Louis, MO).
Ketone bodies were measured enzymatically by following the
appearance of NADH in the conversion to acetoacetate and the
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disappearance of NADH in the conversion to b-hydroxybutyrate
in the presence of b-hydroxybutyrate dehydrogenase [19].
Nineteen of the common amino acids (except tryptophan) and
ammonia were fluorescently labeled using the AccQ-Tag system
(Waters Co., Milford, MA), separated by high-performance liquid
chromatography (HPLC; Model 2690, Waters Co.) and quantified
by a fluorescence detector (Model 474, Waters Co.), as previously
described [18]. Lactate was measured using the enzymatic
conversion to pyruvate and hydrogen peroxide with lactate
oxidase from a commercially available kit (Trinity Biotech,
Berkeley Heights, NJ). Albumin concentration was determined
by an enzyme-linked immunosorbent assay using a polyclonal
antibody to rat albumin [20]. A standard curve was derived using
chromatographically purified rat albumin (Cappel Laboratories,
Aurora, OH) dissolved in medium. Note that the dialyzer
molecular cutoff weight was determined so that albumin could
not pass through, and subsequently did not appear in the
secondary dialysate circuit. Glucose measurements were quantified
with an enzymatic assay kit through conversion to 6-phospho-
gluconate (Glucose assay kit, Sigma).
Statistical Identification of Linear Response Phases
During Perfusion
Linear regressions were performed on the temporal concentra-
tion profiles of each of the metabolites at different time-periods of
the perfusion (e.g. 0–5 hrs, 0–2 hrs, etc.). This was done in order
to identify whether there were multiple distinct metabolic phases
during perfusion. This linear-response phase analysis served the
dual purpose of establishing times to attain stability or recovery in
perfusion, as well as being a necessary prerequisite to calculating
fluxes accurately for metabolic flux analysis (see below for details).
Box-and-whisker plots of the resulting R2 values for each time
period and experimental group were evaluated to identify the
segments of time with highest R2 and minimum variation (See
Appendix S2 for a display of representative time periods). Ischemic
livers were found to exhibit two distinct stable phases between 0–
2 hrs and 2–5 hrs of perfusion. Fresh livers were found to be
generally stable; greatest linearity was seen between 1–5 hrs,
suggesting some degree of equilibration with the perfusate during
the first hour.
Note that all metabolites displayed a generally linear trend line
within the identified periods. However, for a few metabolites the
concentration profiles were flat, which led to low R2 values despite
good fit by visual inspection. These outlier R2 values therefore
were not considered as a violation of the linearity assumption
above. To avoid the analysis being influenced by such artifacts, the
median and quartile analysis, which is more robust against such
outliers, was employed as opposed to the mean and standard
deviation.
Calculation of Fluxes
Fluxes were calculated as the gradient of concentration of each
metabolite (i.e. slope of the linear regression curve) [21] over the
selected segments of perfusion, normalized to the weight of the
liver and averaged for each group. Oxygen and carbon dioxide
fluxes were determined every hour for each liver and were then
averaged for each group over the selected segments of time.
Data Preprocessing and Outlier Analysis
An initial outlier analysis was performed for each measurement
by plotting box-and-whisker diagrams in MATLAB and eliminat-
ing obvious errors (e.g. negative values). This was followed by a
more stringent analysis where for each group any measurement
values above/below mean 6 26 inter-quartile range for that
group were considered outliers.
Metabolic Flux Analysis (MFA)
MFA was performed based on a stoichiometric model for the
metabolic reaction network developed and tested in more detail
previously [18]. The model allows for the estimation of otherwise
inaccessible intracellular reaction fluxes by performing a mass
balance around each intracellular metabolite using measured
extracellular fluxes. The model was originally developed for
perfused hypermetabolic rat livers, and this version uses a total of
28 metabolites and 62 chemical reactions, including TCA and
urea cycles, amino acid metabolism, gluconeogenesis/glycolysis.
The model does not incorporate complete fatty acid and lipid
metabolism, and while the pentose phosphate pathway (PPP) is
included, DNA synthesis/liver regeneration is assumed to be
negligible. The details of these assumptions can be found
elsewhere [18,21]. The primary accommodation of the model
for the gluconeogenic state is the preferential formation of
oxaloacetate and phosphoenolpyruvate from pyruvate rather than
acetyl-CoA, which ultimately favors gluconeogenesis. By contrast,
in a glycolytic state, glycolysis is predominant and favors the
formation of acetyl-CoA via pyruvate. Fluxes 6 and 7 vary
therefore depending on the state of carbohydrate metabolism and
are represented as dotted lines, rather than solid lines, in the
glycolytic case. It is noted here that all perfused livers derived from
Table 1. Measured Influx Values.
Metabolite Influx In vivo* (PV+HA) Perfusion**
Albumin (g/min/g liver) 0.02–0.05 0.00
Lactate (mmol/min/g liver) 0.03–0.1 0.00
Glucose (mg/min/g liver) 1.13–2.5 3.68
Alanine (umol/min/g liver) 0.36–0.92 1.86
Ammonia (umol/min/g liver) 0.11–0.2 0.00
Arginine (umol/min/g liver) 0–0.5 0.53
Asparagine (umol/min/g liver) 0.04–0.12 0.28
Aspartate (umol/min/g liver) 0.02–0.04 0.41
Cysteine (umol/min/g liver) 0.01–0.03 0.61
Glutamate (umol/min/g liver) 0.07–0.15 0.56
Glutamine (umol/min/g liver) 0.28–0.68 3.64
Glycine (umol/min/g liver) 0.26–0.6 1.23
Histidine (umol/min/g liver) 0.1–0.35 0.18
Isoleucine (umol/min/g liver) 0.07–0.23 0.70
Leucine (umol/min/g liver) 0.21–0.66 1.05
Lysine (umol/min/g liver) 0.18–0.54 1.10
Methionine (umol/min/g liver) 0.04–0.1 0.18
Ornithine (umol/min/g liver) 0.11–0.28 0.00
Phenylalanine (umol/min/g liver) 0.05–0.13 0.28
Proline (umol/min/g liver) 0.16–0.36 0.48
Serine (umol/min/g liver) 0.17–0.48 0.18
Threonine (umol/min/g liver) 0.19–0.47 0.62
Tyrosine (umol/min/g liver) 0.05–0.17 0.51
Valine (umol/min/g liver) 0.12–0.43 0.79
*In vivo influx is the combined portal vein (PV) and hepatic artery (HA)
contribution to that flux.
**Perfusate influx is calculated according to the initial perfusate concentrations
and a flow rate of 1.8 ml/min/g liver.
doi:10.1371/journal.pone.0069758.t001
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fed rats while in vivo results were obtained using fasted rats. WE
insulin levels were approximately 10-fold higher than what was
observed in fed rats [8,22] and without glucagon supplementation.
Briefly, in MFA the change in the concentration of intracellular
metabolites is assumed to be zero (pseudo steady-state assumption)
hence the sum of fluxes of each metabolite’s uptake, synthesis and
utilization equals zero: S.v = 0. The matrix S contains the
stoichiometric coefficients of the incorporated reactions. Each
element Sij of S is the coefficient of metabolite i in reaction j, and
each vj of vector v is the net flux or conversion rate of reaction j.
The equation S.v = 0 is separated into measured (vm) and
unknown fluxes (vu), as well as the matrices containing stoichio-
metric coefficients of known (Sm) and unknown reactions (Su):
Su.vu =2Sm.vm. The measured fluxes represent rates of uptake or
release of extracellular metabolites, and by solving the equation
they also give estimates of intracellular fluxes, therefore enabling
an intracellular analysis based on extracellular changes. It should
be noted that if the number of stoichiometric balances (i.e.
independent rows, or equivalently, the rank of matrix Su) are equal
to the number of unknown fluxes then there is a single solution.
Ideally, the unknown fluxes are fewer; in this case the solution
becomes a regression problem. Moreover, in this case the
consistency of measured fluxes within each other and the model
can be validated.
In this work, the model consistency and validity of the steady
state assumption was confirmed by the method of Wang and
Stephanopoulos [23]. Briefly, this approach tests if the errors form
the regression for a chi-square distribution, which indicates a
normal, expectable measurement error distribution. If the
regression errors do not follow a chi-square distribution at
p,0.05, then it is possible to identify the problematic measure-
ments by an iterative elimination process [23] and eliminate
artifactual/inconsistent measurements. This approach was used to
identify two artifactual oxygen uptake measurements which, when
eliminated, resolved the issues observed.
Statistical Analysis
All statistical comparisons between individual fluxes were
performed using 2-tailed Student’s t-test (p,0.05).
Groups Studied
Procured livers were either Fresh (n = 11) or exposed to an hour
of warm ischemia (WI, n= 7) and then perfused, and metabolic
analysis was performed. Note that it was previously demonstrated
that in this model of rat DCD livers, 1 hr WI livers are not
transplantable (0% survival by day 4 post transplant), however
treatment by the NMP system also employed in this work increases
the success to 100% (1 month post-transplant) [6]. Where
necessary for comparison, in vivo values for rats were obtained
and reported from another study [24].
Results
We previously demonstrated that ex vivo normothermic perfu-
sion of Freshly isolated rat livers results in transplantable organs,
and further that the same perfusion system is necessary and
sufficient for the restoration of 1 hr warm ischemic rat livers to
transplantable condition [6]. We further demonstrated that the
metabolic performance of the perfused rat livers are highly
correlated and predictive of ischemia [8] and transplant success
[25]. In this work we perform and provide additional data and
analyses to assess the perfusion recovery time and organ stability.
The systemic impact of perfusion on organ metabolism was
evaluated through metabolic flux analysis.
Overall Metabolic Changes due to Ischemia
Samples of perfusate were taken hourly at the portal vein to
reflect oxygen delivery rate (ODR), and at the infra-hepatic vena
cava to determine oxygen exit rate (OER). Oxygen uptake rate
(OUR) was determined as the difference between ODR and OER
(Figure 1A). ODR and OER were also compared to in vivo
conditions (Figure 1B). WI livers consumed significantly less
oxygen than Fresh livers during the first hour of perfusion, but by
the second hour, consumption had increased to 0.050–0.057 ml
O2/min/g liver and was comparable between groups. WI livers
showed a slow but steady decline in OUR from t = 2–5 hrs, the
difference between WI and Fresh livers again becoming statisti-
cally different at t = 5 hrs. Fresh livers also demonstrated a decline
in OUR initially until t = 3 hrs after which consumption began to
gradually increase again. Figure 1B illustrates that the ODR in
perfusion averages at 0.14 ml O2/min/g liver in both groups, and
falls within one standard deviation of the average in vivoODR. The
OER however, was significantly higher than in vivo, which has
negligible variation in value, demonstrating that despite reduced
oxygen supply, the liver does not consume all that is available to it
in perfusion, regardless of ischemic injury.
Concentration profiles of glucose in both WI and Fresh livers
were generally stable at a value slightly above the original
perfusate glucose content of 2 g/L (Figure 2A).
Figure 1. Oxygen trends in Fresh and WI livers. A) Oxygen uptake
rate (OUR) for WI and Fresh livers. B) Oxygen delivery rate (ODR) and
exit rate (OER) in perfused livers compared to those in vivo. Red and
blue lines represent the range in ODR and OER (average +/2 1std dev);
the range for OER is negligible.
doi:10.1371/journal.pone.0069758.g001
Metabolic Flux Analysis of Ischemic Injury
PLOS ONE | www.plosone.org 4 July 2013 | Volume 8 | Issue 7 | e69758
WI livers produced more lactate than Fresh livers, exceeding the
in vivo upper bound value within the first hour (Figure 2B). The
rate of production subsequently declined resulting in concentra-
tions comparable to Fresh livers by the end of perfusion. Fresh
livers produced lactate linearly throughout, also exceeding the in
vivo upper limits after 2 hours of perfusion. Note that WE perfusate
does not contain any lactate.
Albumin concentration (Figure 3A) increased steadily in Fresh
liver perfusions, reaching a maximum of 0.68 g/dL at t = 4 hrs,
approximately 40% of the in vivo lower bound value. By contrast,
WI livers produced little to no albumin during this time span
(0.0055 g/dL/hr). Urea concentration increased similarly and
linearly in both groups (Figure 3B) at a rate of 4.1 mM/hr,
R2= 0.99 for Fresh livers and 4.4 mM/hr, R2= 0.98 for WI livers.
Urea concentration also did not reach the in vivo lower bound
concentration of approximately 2.8 mM at the end of perfusion.
Ammonia concentration increased similarly in perfusate from zero
to 40 uM in both groups (Figure 3C). The perfusate values of
ammonia were significantly below the in vivo lower bound of
approximately 76 uM. The amino acids methionine (Figure 3D),
tyrosine, proline, lysine and phenylalanine (not shown) were all
consumed at significantly lower rates in WI livers than in Fresh
livers. Glutamine uptake (Figure 3E) occurred at a stable rate that
was similar for both WI and Fresh livers. Rates of uptake between
WI and Fresh livers were also similar for aspartate, alanine,
glycine, asparagine, cysteine and threonine (not shown). WI and
Fresh livers differed significantly in glutamate metabolism
(Figure 3F). Glutamate concentration increased linearly in Fresh
livers but was relatively unchanged in WI livers and remained
within the value present in WE. Arginine (Figure 3G) by contrast
was consumed at a significantly higher rate by WI livers, to the
extent that it became substrate depleted at t = 4 hrs. A reciprocal
increase in ornithine was observed (Figure 3H); a plateau was
reached in the output by WI livers at t = 4 hrs, well above the in
vivo upper bound value. By contrast, a linear increase in ornithine
output by Fresh livers resulted in a perfusate concentration within
in vivo range at t = 5 hrs. WE was deficient in lactate, ornithine,
ammonia, urea, albumin, and ornithine at the onset of perfusion,
and the liver generally increased the concentrations of each of
these metabolites during perfusion. However, in the case of
histidine (Figure 3I) and serine (not shown), both of which are
present in WE at values significantly below the in vivo lower bound,
neither were utilized or contributed to during perfusion. The
branched chain amino acids valine (Figure 3J), isoleucine and
leucine (not shown) were all produced linearly during perfusion by
both groups.
MFA of Fresh vs. Ischemic Perfused Livers
In order to identify whether there were distinct phases in liver
metabolism during perfusion, linear regressions were performed
on the temporal concentration profiles of each of the metabolites.
Box-and-whisker plots of the resulting R2 values were evaluated
for least variation across different segments of time (Appendix S2).
Ischemic livers were found to exhibit stable but distinctly different
metabolic rates between 0–2 hrs and 2–5 hrs of perfusion; MFA
was conducted separately for both phases. Fresh livers were
generally stable throughout perfusion; MFA was performed on the
segment with greatest linearity, determined as being t = 1–5 hrs.
Appendix S3 delineates the results of MFA for all groups.
In Figure 4, the first two hours of ischemic liver perfusion are
compared to Fresh liver metabolism using MFA. The map
suggests ischemic livers were significantly more glycogenolytic
than Fresh livers at NMP onset, breaking down glycogen for
glycolysis and glucose release. Glycolysis appeared to result in a
116% increase in the production of lactate (Flux #8). Oxygen
uptake rate (Fluxes 53–55) and the TCA cycle were comparable
between groups. Ischemic livers demonstrated a preferential
uptake of the amino acid arginine (118% increased in Flux #18)
and a reciprocal 304% increase in the release of ornithine into the
extracellular space (Flux #20). Ischemic livers also showed a 46%
increase in the formation of asparagine from aspartate (Flux #47).
Phenylalanine uptake was increased by 24% (p,0.1, Flux #36)
while tyrosine uptake was reduced by 63% (p,0.05, Flux #38)
resulting in an overall reduction of fumarate production (Flux
#37). Methionine and serine metabolism were significantly
reduced (Flux #44); extracellular serine release was observed at
this time also (Flux #25). Glutamate production (Flux #40) was
58% of that found in Fresh livers, a significant reduction due likely
to a decline in contribution from lysine and 2-oxo-glutarate (Flux
#35), which were reduced by 61% (p,0.1).
Between 2–5 hrs of WI perfusion (Figure 5) more differences
were apparent between Fresh and WI livers than at 0–2 hrs. WI
livers appeared to be mildly gluconeogenic and demonstrated a
30% reduction in lactate output compared to Fresh livers, despite
a further decline in oxygen uptake rate. Contributions to the TCA
cycle via phenylalanine conversion to tyrosine were reduced, such
that fumarate production via this pathway (Flux #37) was only
50% of Fresh liver flux values. Reduced acetyl-CoA and
oxaloacetate (Flux #9) resulted in a 61% reduction of citrate
formation, while threonine conversion to acetyl-CoA was
increased 470%. Glutamate output was further reduced to within
4% of Fresh liver fluxes; contributions to its formation from both
lysine (50% of Fresh livers, Flux #35) and proline (40% of Fresh
livers, Flux #42) impacted its production substantially. There was
however, a 260% increase in glutamate formation via glutamine
(Flux #41), which resulted in a 100% increase in glutamate
Figure 2. Average glucose and lactate concentrations during
NELP of WI and Fresh livers. Dotted line is Williams Medium E (WE),
red line is in vivo upper bound (ave+1 std dev) and blue is in vivo lower
bound (ave – 1 std dev).
doi:10.1371/journal.pone.0069758.g002
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formation of 2-oxo-glutarate (Flux #39). This increased flux
converged on the TCA cycle at a point of reduced incoming fluxes
from citrate, such that the downstream pathway of the cycle was
restored to a value similar to that of Fresh livers. Asparagine to
aspartate production was further increased to a rate 60% greater
than Fresh livers, while tyrosine, methionine and serine metabo-
Figure 3. Average amino acid concentrations during NELP of WI and Fresh livers. Dotted line is Williams Medium E (WE), red line is in vivo
upper bound (ave+1 std dev) and blue is in vivo lower bound (ave – 1 std dev). * Indicates significantly different from Ischemic (p,0.05).
doi:10.1371/journal.pone.0069758.g003
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lism remained reduced, though extracellular serine was then
actively consumed at a higher rate (Flux #25). Arginine uptake
and ornithine output were significantly reduced compared to
Fresh livers, but the increased metabolism of asparagine, threonine
and glutamine resulted in an overall increased urea cycle.
Figure 6 summarizes the MFA findings demonstrating that
perfused liver activity of the major pathways of metabolism
including oxygen uptake, electron transport, lipid oxidation, the
TCA cycle and the PPP was reduced compared to in vivo values
[24]. Lactate production was increased in perfusion while amino
acids and the urea cycle were similar to in vivo livers. All perfused
livers released branched chain amino acids and had negligible
histidine uptake compared to in vivo livers. Perfused livers were
generally glycolytic compared to fasted gluconeogenic in vivo livers,
though extracellular glucose content varied little in concentration
during perfusion.
Discussion
Perfusion systems are capable of significantly impacting the
availability of transplantable organs by optimally supporting donor
organs during storage, and recovering reversibly damaged tissues
through perfusate-based treatment protocols [26,27]. To facilitate
the translation of perfusion technology to clinical use, compre-
hensive and dynamic analyses of organ function during perfusion
are needed that identify parameters critical to organ stability and
recovery. As a first step in this direction, we performed a
comprehensive metabolic analysis to capture the time of ischemic
liver recovery and evaluate the impact of perfusate on organ
stability. We conducted our study on hourly perfusate samples
from Fresh and WI livers that were successfully transplanted after
6 hours of preservation. Through the measurement of 28
metabolites and the calculation of an additional 34 fluxes using
MFA, we were able to evaluate the stability of our perfusion
system, identify perfusate short-comings, and establish significant
differences between Fresh and WI livers useful in the future design
of treatment protocols.
Fresh livers highlighted baseline factors to be considered in
future perfusions. They demonstrated functional stability through
linear changes in metabolite concentrations during perfusion;
greatest stability/linearity was seen after the first hour of perfusion,
likely reflecting a period of adjustment to the ex vivo environment.
There was no evidence of substrate limitation in the perfusate at
t = 6 hours. MFA depicted the expected response to a fed/high
insulin state by showing glucose uptake, glycogen storage and
Figure 4. MFA of phase I (t = 0–2 hrs) for WI livers compared to Fresh livers; Fresh liver MFA forms the black baseline. Red arrows are
significantly increased fluxes. Blue arrows are significantly reduced fluxes and green are reversed. Bold lines = p,0.05, Thin lines = p,0.1, Dotted
lines = glycolysis.
doi:10.1371/journal.pone.0069758.g004
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glycolysis. Alanine and lactate uptake, the usual precursors for
gluconeogenesis were down-regulated and produced, respectively.
The TCA cycle was reduced, as were ketone body production and
fatty acid oxidation, altogether requiring a minimum of oxygen,
concomitant with a high energy state.
Restoration of ischemic livers during perfusion appears to be
correlated with a distinct change in liver metabolism at t = 2 hrs as
seen using linear regression analysis on the temporal concentration
profiles of each of the metabolites. The restoration of oxygen
uptake rates to Fresh liver values at t = 2 hrs, followed by a relative
plateau in oxygen consumption was the most dramatic change
amongst the metabolites measured and coincides with Pastor’s
[28] description that this marks the full recovery of the organ from
ischemic damage. It is interesting to note that in MP applications
typically longer perfusion durations are chosen [4,6] whereas these
results suggest a much shorter time to transplantation may be
sufficient. It is further possible that optimizing the delivery of
oxygen during perfusion may result in even shorter ischemic organ
recovery times [28], as discussed below.
The value of optimal oxygen delivery, in that it is delivered to all
cells at an acceptable rate, is appreciated upon closer inspection of
the data. From in vivo data [24] it can be deduced that a healthy rat
liver consumes approximately 0.25 ml O2/min/g liver in the
fasted state. Rearranging the abovementioned equation to
calculate oxygen concentration, using a pO2 of approximately
500 mHg in perfusion, and assuming a 90% oxygenation of the
hemoglobin present, the maximum value of hemoglobin the liver
needs to ensure sufficient oxygenation at physiological flow rates
and portal pressures is approximately 8 g/dL or 23%. Riedel et.
al. [29] verified experimentally that the optimal hematocrit in
perfusion was approximately 20%, above which oxygen uptake
rates did not increase with flow rates while portal pressures
became destructively high. Similarly, we found that in order to
sustain a physiological perfusion pressure in our system, adjust-
ment of the hematocrit through dialysis was optimal at values
between 15–20%. Nevertheless, despite meeting the oxygen
requirements of the liver, perfused livers did not take up all the
oxygen available to them, suggesting an overall damped rate of
metabolic activity. Several publications concur with our findings of
lower-than-physiological oxygen uptake rates [3,15,30] to the
extent that Mischinger et. al. [13] favor removing erythrocytes
altogether, resulting in a significantly simpler perfusion setup.
Before this can be done however, it is necessary to determine why
the livers are not consuming all the available oxygen.
Figure 5. MFA of phase II (t = 3–5 hrs) for WI livers compared to Fresh livers; Fresh liver MFA forms the black baseline. Red arrows are
significantly increased fluxes. Blue arrows are significantly reduced fluxes and green are reversed. Bold lines = p,0.05, Thin lines = p,0.1, Dotted
lines = glycolysis.
doi:10.1371/journal.pone.0069758.g005
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It is possible that livers in perfusion are functionally incapable of
maximizing oxygen extraction. There may be several mechanisms
potentially involved in this response: The first, alluded to in the
discussion on Fresh livers above, may simply be that livers in
perfusion do not need to be as metabolically active in their non-
demanding ex vivo environment. Alternatively, the delivery of
perfusate oxygen at the lowest range of typical in vivo values for
prolonged periods of time (hours) (Figure 1) may be resulting in a
systemic hypoxia-induced mitochondrial inhibition [31]. Third,
the metabolic consequences of ischemia reperfusion injury may be
causing localized areas of hypoperfusion in the microvasculature
[32,33].
Several factors have been implicated in the metabolic response
to hypoxia, which serve to minimize organ dependence on oxygen
by reducing anabolic pathways and increasing catabolic pathways,
using anaerobic respiration as the end-point:
Hypoxia-inducible factor (HIF) [31], as the name suggests, is
rapidly incurred during periods of low or insufficient oxygen. HIF
strongly induces glycolysis, also referred to as the Pasteur effect
[34], as seen dominantly in Figure 4, Fluxes #2–6. HIF is also
responsible for the preferential formation of lactate from pyruvate
(Flux #8) by upregulation of lactate dehydrogenase. This serves to
enable the production of ATP, while decreasing the contribution
of acetyl-CoA to the TCA cycle (Flux #9), effectively inhibiting it
[35] (Fluxes #9–14), thereby reducing cellular dependence on
oxygen. Also, HIF induces pyruvate dehydrogenase (PDH) kinase-
1 that phosphorylates and inactivates PDH, the mitochondrial
enzyme that converts pyruvate into acetyl-CoA. Our findings do
not suggest that the rate of formation of acetyl-CoA from pyruvate
is impeded by warm ischemia, however in all perfused livers, the
TCA cycle is reduced compared to in vivo. Therefore, the results of
MFA generally agree with these expected effects of HIF,
suggesting the persistence of hypoxia in both ischemic and Fresh
livers.
AMP-activated protein kinase (AMPK) is also stimulated during
hypoxia and ischemia, and functions to suppress the overall
metabolic rate and hence energy requirements of cells for self-
preservation [36]. AMPK is associated with increasing glycolysis
and minimizing gluconeogenesis [37] thereby largely coinciding
with the effects of HIF and the MFA findings. It is also associated
with increasing lipid oxidation and decreasing fat storage, notably
opposing many insulin pathways [38,39], which is not observed in
the MFA. The preferential reduction in palmitate oxidation (Flux
#48) seen in Figures 4–6 illustrates the likely domination of a high
insulin state over AMPK, controlling lipid metabolism. It is
unclear at this point whether promoting the reduction of lipid
oxidation through higher insulin values is an effective means of
reducing the damaging consequences of lipid peroxidation at the
expense of reduced ATP production; subsequently further
optimization of perfusate insulin and fatty acid levels is necessary.
Nitric oxide (NO) has been identified as another important
determinant of metabolism during hypoxia, facilitating the
distribution of available oxygen both at the mitochondrial and
vascular scale [40,41]. In the mitochondrion, there is an increased
NO accumulation at low O2 levels, when cytochrome c oxidase is
primarily reduced. NO actively competes with the enzyme and
suppresses the respiratory rate, which coincides with the effects of
HIF [40,41,42,43,44,45]. Increased intracellular NO has also been
shown to reduce protein synthesis, which requires energy
expenditure, during hypoxia [36], in particular inhibiting the
formation of albumin, the effects of which may last for several
hours after NO exposure [46]. From our findings, albumin
synthesis in WI livers remained flat for the duration of perfusion
(Figure 3), while Fresh livers began to recover by t = 2 hours,
logically suggesting they had less NO exposure. At the vascular
level, the accumulation of NO intracellularly results in reduced
NO secretion, and subsequent vasoconstriction that serve to
extend the ischemic time despite initiation of reperfusion [47].
Alteration of NO production is also supported by the compara-
tively increased extracellular arginine uptake seen in WI livers,
with a reciprocal increase in ornithine production. Arginine is a
precursor for NO, but the balance between arginases and nitric
oxide synthases are dramatically altered during hypoxia [42,48,49]
Figure 6. Summary of major pathways in perfused livers normalized to in vivo values.
doi:10.1371/journal.pone.0069758.g006
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possibly favoring an ineffective shuttling of arginine to ornithine as
opposed to the desirable production of NO.
Given the importance of adequate oxygenation during perfu-
sion, one possible consideration is to reduce the liver’s dependence
on oxygen even further by reducing the perfusate temperature,
which has also been associated with less post-ischemic vasocon-
striction [50]. We [11,51] and others [52] have shown that room
temperature perfusion significantly reduces whole organ metabo-
lism but still results in viable, transplantable organs. This could
also ensure that use of erythrocytes as oxygen carriers is not
necessary. The combination of erythrocyte removal and room
temperature perfusion would simplify the machine perfusion
approach substantially, addressing a major factor in the reluctance
to utilize machine perfusion systems clinically. Further measures to
ensure patent microvasculature [12] and desirable flow rates
would be the addition of thrombolytics, edema-reducing colloids
or impermeants, and vasodilators, including arginine [53,54,55].
The reduced metabolic demand on the ex vivo liver effectively
minimizes the perfusate requirements to keep the liver alive and
assess its function. Amino acids may offer the greatest room for
further perfusate optimization. Their metabolism in perfused livers
helpfully reflected the livers’ abilities to restore perfusate content to
physiological levels and utilize particular amino acids for specific
applications, such as the vasodilatation function of arginine. Fisher
and Kerly [56], who performed analyses of amino acid metabo-
lism in healthy fasted perfused rat livers, also observed a steady
increase in perfusate content of branched chain amino acids
(BCAAs) valine, isoleucine and leucine, as seen in both the Fresh
and WI livers in this work. Further, these authors found both
histidine and glutamate to be unchanged in perfusion; both trends
held true in WI livers. Fresh livers demonstrated a net production
of glutamate, which may be related to a normal transamination of
excessive perfusate amino acids in conjunction with an otherwise
reduced TCA cycle. Together these findings support a high degree
of substrate specificity by the liver in perfusion and a regulated
response to supraphysiological perfusate content. A reduction in
the concentration of some amino acids, including the BCAAs,
histidine and glutamate, may serve to further reduce the metabolic
activity of the liver by reducing urea cycle activity.
Conclusions
In summary, this comprehensive metabolic analysis of the
performance of Fresh and WI livers in normothermic MP
demonstrates sustained organ stability over 5–6 hours of perfusion,
and the restoration of WI livers to a likely transplantable state
within 2 hours of perfusion.
The data presented in this study provide the bases for rational
MP optimization. In particular, lipid oxidation was suppressed,
likely due to the high insulin levels, while amino acids were
extensively metabolized, likely due to supraphysiological perfusate
concentrations. Perfused livers did not consume all the available
oxygen and were hypoxic independent of ischemic injury
suggesting that enhanced microcirculation via vasodilators and
anti-thrombolytics might be an effective approach at optimizing
the delivery of oxygen to hepatocytes in both groups as early in
perfusion as possible.
Further, the data and analyses presented here enable the
conduct of future meta-analyses, such as Flux Balance Analysis
[57,58,59,60], which are necessary steps in the building of
automated feedback control systems for real-time metrics of organ
viability and support [61,62].
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